1
|
Charansol A, Pelletier F, Aubin F, Castelain F. Airborne allergic contact dermatitis from beeswax and propolis in a beekeeper: A story from long ago. Contact Dermatitis 2024; 90:536-538. [PMID: 38332394 DOI: 10.1111/cod.14515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 01/18/2024] [Accepted: 01/22/2024] [Indexed: 02/10/2024]
Affiliation(s)
| | - Fabien Pelletier
- Department of Dermatology, University Hospital, Besançon, France
- University of Franche-Comté, Inserm RIGHT U1098, Besançon, France
| | - François Aubin
- Department of Dermatology, University Hospital, Besançon, France
- University of Franche-Comté, Inserm RIGHT U1098, Besançon, France
| | | |
Collapse
|
2
|
Castelain F, Sueur P, Aubin F, Pelletier F. Protein contact dermatitis to a tan-extender lotion: Imputability of pumpkin seed oil (Luffa cylindrica seed oil). Contact Dermatitis 2024; 90:435-437. [PMID: 38164070 DOI: 10.1111/cod.14492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 12/06/2023] [Accepted: 12/12/2023] [Indexed: 01/03/2024]
Affiliation(s)
| | - Pauline Sueur
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
| | - François Aubin
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
- University of Franche-Comté, Inserm U1098, Besançon, France
| | - Fabien Pelletier
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
- University of Franche-Comté, Inserm U1098, Besançon, France
| |
Collapse
|
3
|
Rossignol J, Canioni D, Aouba A, Bulai-Livideanu C, Barete S, Lancesseur C, Polivka L, Madrange M, Ballul T, Neuraz A, Greco C, Agopian J, Brenet F, Dubreuil P, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Gourguechon C, Frenzel L, Meni C, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Hamidou M, Neel A, Ranta D, Jaussaud R, Guilpain P, Molina TJ, Bruneau J, Lhermitte L, Garcelon N, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Heiblig M, Dimicoli-Salazar S, Torregrosa-Diaz JM, Soria A, Arock M, Lortholary O, Bodemer C, Pol S, Mallet V, Hermine O, Damaj G. Histological characterization of liver involvement in systemic mastocytosis. Liver Int 2024. [PMID: 38554045 DOI: 10.1111/liv.15913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Revised: 03/11/2024] [Accepted: 03/14/2024] [Indexed: 04/01/2024]
Abstract
BACKGROUND AND AIMS Systemic mastocytosis (SM) is characterized by the accumulation of atypical mast cells (MCs) in organs. Liver histology of SM has been marginally described and accurate histological classification is critical, given the consequences of aggressive SM diagnosis. We aimed to describe the histological features associated with liver SM using updated tools. METHODS Using the database of the French Reference Centre for Mastocytosis, we retrospectively identified patients with a liver biopsy (LB) and a diagnosis of SM. All LB procedures were performed according to the local physician in charge and centrally reviewed by an expert pathologist. RESULTS A total of 28 patients were included: 6 had indolent SM, 9 had aggressive SM, and 13 had SM with an associated hematologic neoplasm. Twenty-five (89%) patients presented hepatomegaly, and 19 (68%) had portal hypertension. The LB frequently showed slight sinusoid dilatation (82%). Fibrosis was observed in 3/6 indolent SM and in almost all advanced SM cases (21/22), but none of them showed cirrhosis. A high MC burden (>50 MCs/high-power field) was correlated with elevated blood alkaline phosphatase levels (p = .030). The presence of portal hypertension was associated with a higher mean fibrosis grade (1.6 vs. 0.8 in its absence; p = .026). In advanced SM, the presence of nodular regenerative hyperplasia (NRH) was associated with decreased overall survival (9.5 vs. 46.3 months, p = .002). CONCLUSIONS MC infiltration induced polymorphic hepatic lesions and the degree of fibrosis is associated with portal hypertension. NRH identifies a poor prognosis subgroup of patients with advanced SM. Assessing liver histology can aid in SM prognostic evaluation.
Collapse
Affiliation(s)
- Julien Rossignol
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Danielle Canioni
- CEREMAST, Department of Pathology, Necker Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Achille Aouba
- Department of Internal Medicine, Normandy University School of Medicine, Caen, France
| | | | - Stéphane Barete
- CEREMAST, Dermatology Department, Pitié-Salpêtrière Hospital, AP-HP, Paris, France
| | - Charles Lancesseur
- CEREMAST, Hematology Institute, Normandy University School of Medicine, Caen, France
| | - Laura Polivka
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Marine Madrange
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Thomas Ballul
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Antoine Neuraz
- Department of Bioinformatics, Necker Children's Hospital, AP-HP, Paris Centre University, Imagine Institute, INSERM U1163, Paris, France
| | - Celine Greco
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Julie Agopian
- Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France
- Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Marseille, France
| | - Fabienne Brenet
- Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France
- Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Marseille, France
| | - Patrice Dubreuil
- Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France
- Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Marseille, France
| | - Richard Lemal
- Histocompatibility Laboratory, EA 7453-Université Clermont Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | - Olivier Tournilhac
- CEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand, France
| | - Louis Terriou
- CEREMAST, Department of Internal Medicine and Clinical Immunology, CHU Lille, Lille, France
| | - David Launay
- CEREMAST, Department of Internal Medicine and Clinical Immunology, CHU Lille, Lille, France
- Lille University, INSERM U1286 INFINITE, CHU Lille, Lille, France
| | - Laurence Bouillet
- CEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble, France
| | | | - Laurent Frenzel
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Cécile Meni
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | | | - Marie Gousseff
- Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique, Vannes, France
| | - Edwige Le Mouel
- CEREMAST, Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France
| | - Mohamed Hamidou
- CEREMAST, Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France
| | - Antoine Neel
- CEREMAST, Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France
| | - Dana Ranta
- Department of Hematology, Nancy University Hospital, Nancy, France
| | - Roland Jaussaud
- Department of Internal Medicine and Clinical Immunology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
| | - Philippe Guilpain
- CEREMAST, Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier, France
| | - Thierry J Molina
- CEREMAST, Department of Pathology, Necker Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Julie Bruneau
- CEREMAST, Department of Pathology, Necker Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Ludovic Lhermitte
- CEREMAST, Laboratory of Onco-Hematology, Necker Children's Hospital, APHP, Paris, France
| | - Nicolas Garcelon
- Paris Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, Paris, France
| | - Rose-Marie Javier
- CEREMAST, Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France
| | - Fabien Pelletier
- CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon, France
| | - Florence Castelain
- CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon, France
| | - Frederique Retornaz
- Unité de soins et de recherche en médecine interne et maladies infectieuses, European Hospital, Marseille, France
| | - Quentin Cabrera
- Department of Haematology, Sud Reunion University Hospital, Saint Pierre, La Réunion, France
| | - Patricia Zunic
- Department of Haematology, Sud Reunion University Hospital, Saint Pierre, La Réunion, France
| | | | | | - Jean François Viallard
- Department of Internal Medicine and Infectious Diseases, Haut-Lévêque Hospital, CHRU Bordeaux, Bordeaux University, Bordeaux, France
| | - Christian Lavigne
- CEREMAST, Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France
| | - Cyrille Hoarau
- CEREMAST, Service d'Immunologie Clinique et d'Allergologie, Centre Hospitalier Régional Universitaire, Tours, France
| | - Isabelle Durieu
- CEREMAST, Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon, France
| | - Maël Heiblig
- CEREMAST, Department of Hematology, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France
| | | | | | - Angèle Soria
- CEREMAST, Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris, France
| | - Michel Arock
- CEREMAST, Laboratory of Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France
| | - Olivier Lortholary
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
- Infectious and Tropical Diseases Department, Necker-Pasteur Infectiology Center, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Christine Bodemer
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Stanislas Pol
- AP-HP.Centre Université Paris Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et spécialités médico-chirurgicales, Service d'Hépatologie, Paris, France
| | - Vincent Mallet
- AP-HP.Centre Université Paris Centre, Groupe Hospitalier Cochin Port Royal, DMU Cancérologie et spécialités médico-chirurgicales, Service d'Hépatologie, Paris, France
| | - Olivier Hermine
- CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker Children's Hospital, Paris Centre University, Paris, France
| | - Ghandi Damaj
- CEREMAST, Hematology Institute, Normandy University School of Medicine, Caen, France
| |
Collapse
|
4
|
Sueur P, Pelletier F, Girardin P, Moumane L, Jeand'Heur A, Aubin F, Castelain F. First case of protein contact dermatitis after botulinum toxin injection, related to a human albumin's allergy. Contact Dermatitis 2024. [PMID: 38469666 DOI: 10.1111/cod.14538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Revised: 01/23/2024] [Accepted: 02/24/2024] [Indexed: 03/13/2024]
Affiliation(s)
- Pauline Sueur
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
| | - Fabien Pelletier
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
- Inserm Unit 1098, Université de Franche Comté, Besançon, France
| | - Pascal Girardin
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
| | | | | | - François Aubin
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
- Inserm Unit 1098, Université de Franche Comté, Besançon, France
| | | |
Collapse
|
5
|
Castelain F, Aubin F, Pelletier F. Contact allergy to Butyrospermum parkii butter in a patient with cheilitis. Contact Dermatitis 2024; 90:323-324. [PMID: 38123238 DOI: 10.1111/cod.14478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Revised: 11/24/2023] [Accepted: 11/29/2023] [Indexed: 12/23/2023]
Affiliation(s)
| | - Francois Aubin
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
- Department of Dermatology, University of Franche-Comté, Inserm U1098, Besançon, France
| | - Fabien Pelletier
- Department of Dermatology, Jean-Minjoz Hospital, Besançon, France
- Department of Dermatology, University of Franche-Comté, Inserm U1098, Besançon, France
| |
Collapse
|
6
|
Traineau H, Milpied B, Soria A, Assier H, Tetart F, Bernier C, Le Bouëdec MCF, Gener G, Kurihara F, Bauvin O, Delauney J, Amsler E, Bara C, Pelletier F, Valois A, Castelain F, de Risi Pugliese T, Hamelin A, Barbaud A. In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study. J Allergy Clin Immunol Pract 2024; 12:460-468. [PMID: 37863314 DOI: 10.1016/j.jaip.2023.10.021] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 09/26/2023] [Accepted: 10/10/2023] [Indexed: 10/22/2023]
Abstract
BACKGROUND Few studies have evaluated allergy workup in fixed drug eruption (FDE) in a large population. OBJECTIVE To evaluate the sensitivity of a standardized allergy workup for diagnosing the cause of FDE, with a focus on in situ repeated open application tests (ROATs). METHODS In a retrospective multicenter study, we analyzed the practice of conducting a complete allergy workup for the etiological diagnosis of FDE. It consisted of 3 steps: in situ patch tests (PTs) for all cases except pure mucosal involvement, followed by in situ ROAT if in situ PT results were negative, and finally a drug challenge (DC). The in situ ROAT involved daily application of the suspected drug on a previously affected FDE site for 7 days. RESULTS Of 98 suspected FDE cases, 61 patients (median age 61 y; male-to-female ratio 1.8) with a complete allergy workup were included. In 4 cases, even the DC yielded negative results. Among the remaining 57 patients with a positive workup, implicated drugs included paracetamol (12 cases), β-lactams (11 cases), imidazoles (9 cases, including 5 with metronidazole), nonsteroidal anti-inflammatory drugs (8 cases), iodinated contrast media (4 cases), cotrimoxazole (3 cases), and various other drugs in 10 patients. The diagnosis was confirmed by in situ PT in 17 of 54 cases (31.5%), in situ ROAT in 14 of 40 cases (35%) (with 4 cases showing remote reactivation of FDE sites), and DC in 26 cases. CONCLUSIONS The sequential allergy workup involving successively in situ PT, in situ ROAT, and DC is a reliable and safe method for diagnosing the cause of FDE. In situ tests exhibited a sensitivity of over 50%.
Collapse
Affiliation(s)
- Hélène Traineau
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Brigitte Milpied
- Centre hospitalo-universitaire (CHU) de Bordeaux, Dermatology department, Saint André hospital, Bordeaux, France
| | - Angèle Soria
- Cimi-Paris Inserm 1135, AP-HP, Sorbonne University, Hôpital Tenon, Dermatology and allergology department, Paris, France
| | - Haudrey Assier
- Dermatology department, AP-HP, Henri Mondor hospital, Créteil, France
| | | | | | | | - Gwendeline Gener
- Dermatology department, AP-HP, Henri Mondor hospital, Créteil, France
| | - Flore Kurihara
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | | | - Juliette Delauney
- CHU d'Angers, Dermatology department, Centre hospitalier de Cholet, Angers, France
| | - Emmanuelle Amsler
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Corina Bara
- Dermatology department, Centre hospitalier du Mans, Le Mans, France
| | | | - Aude Valois
- Dermatology department, Hôpital d'instruction des armées Sainte Anne, Toulon, France
| | | | - Tullia de Risi Pugliese
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Aurore Hamelin
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
| | - Annick Barbaud
- Médecine Sorbonne Universiy, Dermatology and allergology department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
| |
Collapse
|
7
|
Kalmi G, Nguyen Y, Amarger S, Aubineau M, Bibes B, Blanchard-Delaunay C, Boccon-Gibod I, Bouillet L, Coppo P, Dalmas MC, Debord-Peguet S, Defendi F, Demoreuil C, Du-Thanh A, Gayet S, Hadjadj J, Jeandel PY, Launay D, Ly KH, Avoy CM, Niault M, Ollivier Y, Pelletier F, Porneuf M, Roos-Weil D, Fain O, Gobert D. Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency. J Allergy Clin Immunol Pract 2024; 12:212-222. [PMID: 37844846 DOI: 10.1016/j.jaip.2023.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 09/28/2023] [Accepted: 10/10/2023] [Indexed: 10/18/2023]
Abstract
BACKGROUND Angioedema (AE) due to acquired C1-inhibitor (C1-INH) deficiency (AAE-C1-INH) is related to excessive consumption of C1-INH or to anti-C1-INH antibodies, and is frequently associated with lymphoproliferative syndromes or monoclonal gammopathies. Standard of care for prophylactic treatment in this condition is not established. Rituximab may be effective to prevent attacks, especially if the lymphoid hemopathy is controlled, but data are scarce. OBJECTIVE To evaluate efficacy of rituximab in AAE-C1-INH. METHODS A retrospective multicenter study was carried out in France, including patients with AAE-C1-INH treated with rituximab between April 2005 and July 2019. RESULTS Fifty-five patients with AAE-C1-INH were included in the study, and 23 of them had an anti-C1-INH antibody. A lymphoid malignancy was identified in 39 patients, and a monoclonal gammopathy in 9. There was no associated condition in 7 cases. Thirty patients received rituximab alone or in association with chemotherapy (n = 25). Among 51 patients with available follow-up, 34 patients were in clinical remission and 17 patients had active AE after a median follow-up of 3.9 years (interquartile range, 1.5-7.7). Three patients died. The presence of anti-C1-INH antibodies was associated with a lower probability of AE remission (hazard ratio, 0.29 [95% CI, 0.12-0.67]; P = .004). Relapse was less frequent in patients with lymphoma (risk ratio, 0.27 [95% CI, 0.09-0.80]; P = .019) and in patients treated with rituximab and chemotherapy (risk ratio, 0.31 [95% CI, 0.12-0.79]; P = .014). CONCLUSIONS Rituximab is an efficient and well-tolerated therapeutic option in AE, especially in lymphoid malignancies and in the absence of detectable anti-C1-INH antibodies.
Collapse
Affiliation(s)
- Galith Kalmi
- Internal Medicine Department, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France.
| | - Yann Nguyen
- Internal Medicine Department, Nord-Université Paris Cité, AP-HP, Hôpital Beaujon, Clichy-sous-Bois, France
| | - Stephanie Amarger
- Dermatology Department, University Hospital, Clermont-Ferrand, France
| | - Magali Aubineau
- Internal Medicine Department, Hospices Civils de Lyon, Lyon, France
| | - Beatrice Bibes
- Internal Medicine Department, Saint Grégoire Hospital, Rennes, France
| | | | - Isabelle Boccon-Gibod
- Internal Medicine Department, French National Reference Center for Angioedema (CREAK), Grenoble University Hospital, Grenoble, France
| | - Laurence Bouillet
- Internal Medicine Department, French National Reference Center for Angioedema (CREAK), Grenoble University Hospital, Grenoble, France; University Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France; Internal Medicine Department, University Hospital La Tronche, Grenoble, France
| | - Paul Coppo
- Hematology Department, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France
| | | | | | - Federica Defendi
- Immunology Department, Grenoble University Hospital, Grenoble, France
| | - Claire Demoreuil
- Internal Medicine Department, La Cavale Blanche University Hospital, Brest, France
| | - Aurélie Du-Thanh
- Dermatology Department, Montpellier University Hospital, Montpellier, France
| | - Stephane Gayet
- Internal Medicine Department, La Timone University Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France
| | - Jerôme Hadjadj
- Internal Medicine Department, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France
| | | | - David Launay
- Internal and Immunological Medicine Department, Lille Hospital, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille University, INSERM F-59000, Lille, France
| | - Kim Heang Ly
- Internal Medicine Department, Dupuytren University Hospital, Limoges, France
| | - Chloé Mc Avoy
- Internal Medicine Department, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France
| | - Mathilde Niault
- Hematology Department, Hôpital du Scorff-Lorient, Groupe Hospitalier Bretagne Sud, Lorient, France
| | - Yann Ollivier
- Medicine Department, Cote de Nacre University Hospital, Caen, France
| | - Fabien Pelletier
- Dermatology Department, Allergology Center, Besançon University Hospital, Besançon, France
| | - Marc Porneuf
- Hematology Department, Centre Hospitalier Yves le Foll, Saint-Brieuc, France (x)Hematology Department, Sorbonne Université, AP-HP, Pitié Salpêtrière Hospital, Paris, France
| | - Damien Roos-Weil
- Hematology Department, Centre Hospitalier Yves le Foll, Saint-Brieuc, France (x)Hematology Department, Sorbonne Université, AP-HP, Pitié Salpêtrière Hospital, Paris, France
| | - Olivier Fain
- Internal Medicine Department, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France
| | - Delphine Gobert
- Internal Medicine Department, Sorbonne Université, AP-HP, Hôpital Saint Antoine, Paris, France
| |
Collapse
|
8
|
Polivka L, Madrange M, Bulai-Livideanu C, Barete S, Ballul T, Neuraz A, Greco C, Agopian J, Brenet F, Dubreuil P, Burdet C, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Gourguechon C, Damaj G, Frenzel L, Meni C, Bouktit H, Collange AF, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Hamidou M, Neel A, Ranta D, Jaussaud R, Guilpain P, Canioni D, Molina TJ, Bruneau J, Lhermitte L, Garcelon N, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Heiblig M, Dimicoli-Salazar S, Torregrosa-Diaz JM, Soria A, Arock M, Lortholary O, Bodemer C, Hermine O, Rossignol J. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes. J Allergy Clin Immunol 2024; 153:349-353.e4. [PMID: 37633651 DOI: 10.1016/j.jaci.2023.08.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 06/22/2023] [Accepted: 08/08/2023] [Indexed: 08/28/2023]
Abstract
BACKGROUND Mastocytosis and monoclonal mast cell (MC) activation syndrome (MMAS) are heterogeneous conditions characterized by the accumulation of atypical MCs. Despite the recurrent involvement of KIT mutations, the pathophysiologic origin of mastocytosis and MMAS is unclear. Although hereditary α-tryptasemia (HαT, related to TPSAB1 gene duplication) is abnormally frequent in these diseases, it is not known whether the association is coincidental or causal. OBJECTIVE We evaluated the prevalence of HαT in all mastocytosis subtypes and MMAS and assessed the pathophysiologic association with HαT. METHODS Clinical data, laboratory data, KIT mutations, TPSAB1 duplication (assessed by droplet digital PCR), and HαT prevalence were retrospectively recorded for all patients with mastocytosis and MMAS registered in the French national referral center database and compared to a control cohort. To increase the power of our analysis for advanced systemic mastocytosis (advSM), we pooled our cohort with literature cases. RESULTS We included 583 patients (27 with MMAS and 556 with mastocytosis). The prevalence of HαT in mastocytosis was 12.6%, significantly higher than in the general population (5.7%, P = .002) and lower than in MMAS (33.3%, P = .02). HαT+ patients were more likely to have anaphylactic reactions and less likely to have cutaneous lesions than HαT- patients (43.0% vs 24.4%, P = .006; 57.7% vs 75.6%, respectively, P = .006). In the pooled analysis, the prevalence of HαT was higher in advSM (11.5%) than in control cohorts (5.2%, P = .01). CONCLUSION Here we confirm the increase incidence of anaphylaxis in HαT+ mastocytosis patients. The increased prevalence of HαT in all subtypes of systemic mastocytosis (including advSM) is suggestive of pathophysiologic involvement.
Collapse
Affiliation(s)
- Laura Polivka
- Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France
| | - Marine Madrange
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France
| | | | - Stéphane Barete
- CEREMAST, the Department of Dermatology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France
| | - Thomas Ballul
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Antoine Neuraz
- Department of Bioinformatics, Necker-Children's Hospital, AP-HP, Paris Centre University, Imagine Institute, INSERM U1163, Paris, France
| | - Celine Greco
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Julie Agopian
- Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France; Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Marseille, France
| | - Fabienne Brenet
- Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France; Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Marseille, France
| | - Patrice Dubreuil
- Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France; Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Marseille, France
| | - Charles Burdet
- Centre d'Investigation Clinique, INSERM CIC 1425, AP-HP, Bichat Hospital, Paris Centre University, Paris, France
| | - Richard Lemal
- Histocompatibility Laboratory, EA 7453, Université Clermont Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | - Olivier Tournilhac
- CEREMAST, the Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453, Clermont Auvergne University, Clermont-Ferrand, France
| | - Louis Terriou
- CEREMAST, the Department of Internal Medicine and Clinical Immunology, Claude Huriez Hospital, CHRU Lille, Lille, France
| | - David Launay
- CEREMAST, the Department of Internal Medicine and Clinical Immunology, Claude Huriez Hospital, CHRU Lille, Lille, France; Lille University, INSERM U995 LIRIC, CHU Lille, and Referral Center for Rare Systemic Autoimmune Diseases North and North-west of France, Lille, France
| | - Laurence Bouillet
- CEREMAST, the Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble, France
| | | | - Ghandi Damaj
- CEREMAST, the Haematology Institute, Normandy University School of Medicine, Caen, France
| | - Laurent Frenzel
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Cécile Meni
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France
| | - Hassiba Bouktit
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France
| | - Anne Florence Collange
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France
| | - Caroline Gaudy-Marqueste
- CEREMAST, the Department of Dermatology, Aix-Marseille University, CHU Timone, Marseille, France
| | - Marie Gousseff
- Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique, Vannes, France
| | - Edwige Le Mouel
- CEREMAST, the Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France
| | - Mohamed Hamidou
- CEREMAST, the Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France
| | - Antoine Neel
- CEREMAST, the Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France
| | - Dana Ranta
- Department of Haematology, Nancy University Hospital, Nancy, France
| | - Roland Jaussaud
- Department of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy, France
| | - Philippe Guilpain
- CEREMAST, the Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier, France
| | - Danielle Canioni
- CEREMAST, the Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Thierry Jo Molina
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Julie Bruneau
- CEREMAST, the Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France
| | - Ludovic Lhermitte
- CEREMAST, the Laboratory of Onco-hematology, Necker Children's Hospital, AP-HP, Paris, France
| | - Nicolas Garcelon
- Paris Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, F-75015, Paris, France
| | - Rose-Marie Javier
- CEREMAST, the Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France
| | - Fabien Pelletier
- CEREMAST, the Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon, France
| | - Florence Castelain
- CEREMAST, the Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon, France
| | - Frederique Retornaz
- Unité de soins et de recherche en médecine interne et maladies infectieuses, European Hospital, Marseille, France
| | - Quentin Cabrera
- Department of Haematology, Sud Reunion University Hospital, Saint Pierre, La Réunion, France
| | - Patricia Zunic
- Department of Haematology, Sud Reunion University Hospital, Saint Pierre, La Réunion, France
| | | | | | - Jean François Viallard
- Department of Internal Medicine and Infectious Diseases, Haut-Lévêque Hospital, CHRU Bordeaux, Bordeaux University, Bordeaux, France
| | - Christian Lavigne
- CEREMAST, the Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France
| | - Cyrille Hoarau
- CEREMAST, the Service d'Immunologie Clinique et d'Allergologie, Centre Hospitalier Régional Universitaire, Tours, France
| | - Isabelle Durieu
- CEREMAST, the Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon, France
| | - Maël Heiblig
- CEREMAST, the Department of Hematology, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France
| | | | | | - Angèle Soria
- CEREMAST, the Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris, France
| | - Michel Arock
- CEREMAST, the Laboratory of Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France
| | - Olivier Lortholary
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France
| | - Christine Bodemer
- Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France
| | - Olivier Hermine
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France.
| | - Julien Rossignol
- CEREMAST, the Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France
| |
Collapse
|
9
|
Shahali Y, Doc A, Voidey M, Rigaud H, Campion A, Samier LJ, Pontcharraud R, Tome P, Pelletier F, Demoly P, Rame J. Elaboration et validation d’un questionnaire de qualité de vie chez l’enfant allergique alimentaire (0–18 ans). Revue Française d'Allergologie 2023. [DOI: 10.1016/j.reval.2022.103272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
|
10
|
Sueur P, Castelain F, Charollais R, Aubin F, Pelletier F. Érythème pigmenté fixe bulleux généralisé post-vaccination anti-SARS-CoV-2. Annales de Dermatologie et de Vénéréologie - FMC 2022. [PMCID: PMC9748164 DOI: 10.1016/j.fander.2022.09.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
11
|
Bouillet L, Fain O, Armengol G, Aubineau M, Blanchard-Delaunay C, Dalmas MC, De Moreuil C, Du Thanh A, Gobert D, Guez S, Hoarau C, Jaussaud R, Jeandel PY, Maillard H, Marmion N, Masseau A, Menetrey C, Ollivier Y, Pelletier F, Plu-Bureau G, Sailler L, Vincent D, Bouquillon B, Verdier E, Clerson P, Boccon-Gibod I, Launay D. Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs. Allergy Asthma Proc 2022; 43:406-412. [PMID: 35868842 DOI: 10.2500/aap.2022.43.220046] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Background: Hereditary angioedema (HAE) is characterized by unpredictable and potentially life-threatening attacks of cutaneous and submucosal swelling. Over the past decade, new agents, based on a better understanding of the underlying biologic mechanisms of HAE, have changed the face of long-term prophylaxis (LTP). Objective: The objective was to describe current practices and unmet needs with regard to LTP for HAE in expert centers in France. Methods: The study was conducted in France in 2020. Based on their experience with patients with HAE who had visited their center at least once in the past 3 years, physicians from 25 centers who are expert in the management of HAE were requested to fill in a questionnaire that encapsulated their active patient list, criteria for prescribing LTP, and medications used. They were asked about potential unmet needs with currently available therapies. They were asked to express their expectations with regard to the future of HAE management. Results: Analysis was restricted to 20 centers that had an active patient file and agreed to participate. There were 714 patients with C1 inhibitor (C1-INH) deficiency, of whom 423 (59.2%) were treated with LTP. Altered quality of life triggered the decision to start LTP, as did the frequency and severity of attacks. Ongoing LTP included androgens (28.4%), progestins (25.8%), lanadelumab (25.3%), tranexamic acid (14.2%), intravenous C1-INHs (5.6%), and recombinant C1-INH (0.7%). Twenty-nine percent of the patents with LTP were considered to still have unmet needs. Physicians' concerns varied among therapies: poor tolerability for androgens and progestins, a lack of efficacy for tranexamic acid and progestins, dosage form, and high costs for C1-INHs and lanadelumab. Physicians' expectations encompassed more-efficacious and better-tolerated medications, easier treatment administration for the sake of improved quality of life of patients, and less-expensive therapies. Conclusion: Despite the recent enrichment of the therapeutic armamentarium for LTP, physicians still expressed unmet needs with currently available therapies.
Collapse
Affiliation(s)
- Laurence Bouillet
- From the National Reference Center for Angioedema (CREAK), Department of Internal Medicine, Grenoble Alpes University, Laboratoire T-RAIG, UMR 5525 TIMC-IMAG (UGA-CNRS), Grenoble, France
| | - Olivier Fain
- Department of Internal Medicine, Sorbonne University, AP-HP, Saint Antoine Hospital, Paris, France
| | - Guillaume Armengol
- Department of Internal Medicine, Rouen University Hospital, Rouen, France
| | - Magali Aubineau
- Department of Internal Medicine, Hospices Civils de Lyon, Edouard Herriot Hospital, France
| | | | - Marie-Caroline Dalmas
- Department of Internal Medicine, Hautepierre Hospital, Strasbourg University Hospital, France
| | - Claire De Moreuil
- Department of Internal Medicine, La Cavale Blanche University Hospital, Brest, France
| | - Aurélie Du Thanh
- Department of Dermatology, University Montpellier, Montpellier, France
| | - Delphine Gobert
- Department of Internal Medicine, Sorbonne University, AP-HP, Saint Antoine Hospital, Paris, France
| | - Stéphane Guez
- Allergy Diseases Unit, Internal Medicine and Post-Emergency, GH Pellegrin, Bordeaux University Hospital, Bordeaux, France
| | - Cyrille Hoarau
- Transversal Unit of Allergology and Clinical Immunology, Medicine Department, Tours Regional University Hospital, Tours University, France
| | - Roland Jaussaud
- Department of Internal Medicine and Clinical Immunology, Lorraine University, CHRU-Nancy, Nancy, France
| | - Pierre-Yves Jeandel
- Department of Internal Medicine, Nice University Hospital Center, Côte d'Azur University, Nice, France
| | - Hervé Maillard
- Dermatology Department, Le Mans Regional Hospital, Le Mans, France
| | - Nicolas Marmion
- Department of Medicine, Saint Louis University Hospital, Saint Pierre, Réunion
| | - Agathe Masseau
- Department of Internal Medicine, Nantes University Hospital, Nantes, France
| | | | - Yann Ollivier
- Department of Immuno-Allergology, Caen University Hospital, Caen, France
| | - Fabien Pelletier
- Department of Internal Medicine, Besancon University Hospital, Besancon, France
| | - Geneviève Plu-Bureau
- Department of Gynecology Obstetrics and Reproductive Medicine, Cochin University Hospital, Paris, France
| | - Laurent Sailler
- Internal Medicine, University Hospital Center Toulouse, Toulouse, France
| | - Denis Vincent
- Department of Internal Medicine, Nîmes University Hospital, Nîmes, France
| | | | | | | | - Isabelle Boccon-Gibod
- Department of Internal Medicine, CREAK, ACARE Center of Excellence, Grenoble Alpes University Hospital, France, and
| | - David Launay
- Department of Internal Medicine and Clinical Immunology, Lille University, Inserm, Lille University Hospital, CREAK, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France
| |
Collapse
|
12
|
Singh T, Vanhaecke C, Lambert-Dessoy D, Rey D, Boyer L, Galempoix JM, Muller P, Bottlaender L, Dolisi E, Demettre R, Aubin F, Pelletier F, Viguier M. Le déconfinement de 2020 s’est-il accompagné d’un effet « boom » des infections sexuellement transmissibles ? Annales de Dermatologie et de Vénéréologie - FMC 2021. [PMCID: PMC8603745 DOI: 10.1016/j.fander.2021.09.502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Introduction Le confinement strict de mars 2020, visant à contenir la pandémie de SARS-CoV-2, a réduit l’accès aux soins et les interactions sociales. Nous avons souhaité en étudier les conséquences sur l’incidence des infections sexuellement transmissibles (IST). Matériel et méthodes Étude rétrospective, multicentrique, des tests de dépistage du Chlamydiatrachomatis (CT), du gonocoque (NG), de la syphilis, du VIH et du VHB réalisés dans les CeGIDD du Grand Est, entre le 18/03 et le 31/08/2020 avec analyse en 4 sous-périodes : confinement strict (18/03–10/05)/limitation des déplacements dans un périmètre de 100 km (11/05–01/06)/1re partie des levées de restriction en juin (02/06–30/06)/2e partie en juillet–août (01/07–31/07), comparativement aux mêmes périodes de 2018 et 2019. Résultats Durant la période de confinement strict, le nombre de tests effectués était significativement réduit (–95 %) avec une incidence de chaque IST stable, avec des observations similaires pendant la période de déplacement restreint (baisse > 50 % des dépistages totaux). Dès le mois de juin, alors que le nombre de tests effectués devenait comparable à celui des années antérieures, on commençait à noter une hausse significative des infections à CT de +8 % et +20 % comparativement à juin 2019 et 2018, alors que l’incidence des autres IST restait alors constante. En juillet–août, l’incidence globale des IST était de +25 % et de +21 %, avec majoration des infections à CT de +46 % et de +56 % par rapport à 2019 et 2018, respectivement. Discussion Nous rapportons ici une augmentation de l’incidence globale des IST durant l’été 2020 dans la région Grand Est, comparativement à l’été 2019 et 2018, marquée surtout par une hausse de l’incidence des cas de CT, suggérant un impact des mesures sanitaires sur le comportement sexuel de la population étudiée. Deux études rétrospectives européennes ont également montré cette tendance à la baisse des tests totaux de dépistages des IST en 2020, avec hausse des cas de CT une fois les restrictions sanitaires levées. Cette recrudescence des cas de CT et son observation précoce dès le déconfinement pourraient suggérer, du fait de l’accessibilité réduite aux CeGIDD pendant le confinement et du caractère principalement asymptomatique des infections à CT, que le comportement des jeunes sexuellement actifs n’ait pas été restreint par le confinement, voire au contraire s’est libéré, comme par opposition à la restriction des libertés. Conclusion Le déconfinement s’est accompagné d’une augmentation d’incidence des IST, que l’on pourrait décrire comme un « IST-boom » durant l’été 2020. Il est important que la communauté médicale en soit informée, notamment pour les IST asymptomatiques, Chlamydia trachomatis en premier lieu, ayant possiblement échappé aux dépistages et qui sont actuellement latentes.
Collapse
|
13
|
Belbézier A, Arnaud M, Boccon-Gibod I, Pelletier F, McAvoy C, Gobert D, Fain O, Du-Thanh A, Launay D, Lupo J, Bouillet L. COVID-19 as a trigger of acute attacks in people with hereditary angioedema. Clin Exp Allergy 2021; 51:947-950. [PMID: 33772888 PMCID: PMC8250827 DOI: 10.1111/cea.13870] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2021] [Revised: 03/16/2021] [Accepted: 03/22/2021] [Indexed: 02/06/2023]
Affiliation(s)
- Aude Belbézier
- Department of Internal Medicine, Grenoble University Hospital, Grenoble, France
| | - Mélanie Arnaud
- Department of Internal Medicine, Grenoble University Hospital, Grenoble, France
| | - Isabelle Boccon-Gibod
- Department of Internal Medicine, Grenoble University Hospital, Grenoble, France.,National Reference Centre for Angioedema, CREAK, France
| | - Fabien Pelletier
- National Reference Centre for Angioedema, CREAK, France.,Department of Internal Medicine, Besancon University Hospital, Besancon, France
| | - Chloé McAvoy
- Service de Médecine Interne, AP-HP, Hôpital Saint Antoine, Sorbonne Université, Paris, France
| | - Delphine Gobert
- National Reference Centre for Angioedema, CREAK, France.,Service de Médecine Interne, AP-HP, Hôpital Saint Antoine, Sorbonne Université, Paris, France
| | - Olivier Fain
- National Reference Centre for Angioedema, CREAK, France.,Service de Médecine Interne, AP-HP, Hôpital Saint Antoine, Sorbonne Université, Paris, France
| | - Aurélie Du-Thanh
- National Reference Centre for Angioedema, CREAK, France.,Department of Dermatology, CHU Montpellier, Montpellier, France
| | - David Launay
- National Reference Centre for Angioedema, CREAK, France.,Department of Internal Medicine, National Reference Centre for Autoimmune and Systemic Rare Diseases, Hospital Claude-Huriez, Université Lille Nord de France, CHRU Lille, Lille, France
| | - Julien Lupo
- CEA, CNRS, Virology Laboratory CHU Grenoble Alpes, IBS, Univ. Grenoble Alpes, Grenoble, France
| | - Laurence Bouillet
- Department of Internal Medicine, Grenoble University Hospital, Grenoble, France.,National Reference Centre for Angioedema, CREAK, France
| |
Collapse
|
14
|
Colas M, Vanhaecke C, Courtieu C, Lambert D, Lihoreau T, Merle C, Guerre-Schmidt A, Ginet-Mermet I, Viguier M, Pelletier F, Aubin F. Étude observationnelle sur l’impact de la prophylaxie pré-exposition de l’infection par le VIH (PrEP) sur les infections sexuellement transmissibles. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
15
|
Dresco F, Castelain F, Pelletier F, Daguindau E, Aubin F, Puzenat E. Mastocytose à début pédiatrique, évolution et impact sur la qualité de vie : étude rétrospective d’une cohorte de 20 patients. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Gobert D, Bouillet L, Armengol G, Coppo P, Defendi F, Du-Thanh A, Hardy G, Javaud N, Jeandel PY, Launay D, Panayotopoulos V, Pelletier F, Boccon-Gibod I, Fain O. Angiœdèmes par déficit acquis en C1-inhibiteur : recommandations du CREAK pour le diagnostic et la prise en charge. Rev Med Interne 2020; 41:838-842. [DOI: 10.1016/j.revmed.2020.06.010] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 06/04/2020] [Accepted: 06/20/2020] [Indexed: 11/29/2022]
|
17
|
Dermer E, Spahr A, Tran LT, Mirchi A, Pelletier F, Guerrero K, Ahmed S, Brais B, Braverman N, Buhas D, Chandratre S, Chenier S, Chrestian N, Desmeules M, Dilenge ME, Laflamme J, Larbrisseau A, Legault G, Lim KY, Maftei C, Major P, Malvey-Dorn E, Marois P, Mitchell J, Nadeau A, Osterman B, Paradis I, Pohl D, Reggin J, Riou E, Roedde G, Rossignol E, Sébire G, Shevell M, Srour M, Sylvain M, Tarnopolsky M, Venkateswaran S, Sullivan M, Bernard G. Stress in Parents of Children With Genetically Determined Leukoencephalopathies: A Pilot Study. J Child Neurol 2020; 35:901-907. [PMID: 32720856 DOI: 10.1177/0883073820938645] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Genetically determined leukoencephalopathies comprise a group of rare inherited white matter disorders. The majority are progressive diseases resulting in early death. We performed a cross-sectional pilot study including 55 parents from 36 families to assess the level of stress experienced by parents of patients with genetically determined leukoencephalopathies, aged 1 month to 12 years. Thirty-four mothers and 21 fathers completed the Parenting Stress Index-4th Edition. One demographic questionnaire was completed per family. Detailed clinical data was gathered on all patients. Statistical analysis was performed with total stress percentile score as the primary outcome. Mothers and fathers had significantly higher stress levels compared with the normative sample; 20% of parents had high levels of stress whereas 11% had clinically significant levels of stress. Mothers and fathers had comparable total stress percentile scores. We identified pediatric behavioral difficulties and gross motor function to be factors influencing stress in mothers. Our study is the first to examine parental stress in this population and highlights the need for parental support early in the disease course. In this pilot study, we demonstrated that using the Parenting Stress Index-4th Edition to assess stress levels in parents of patients with genetically determined leukoencephalopathies is feasible, leads to valuable and actionable results, and should be used in larger, prospective studies.
Collapse
Affiliation(s)
- E Dermer
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada.,E. Dermer and A. Spahr are co-first authors of this article
| | - A Spahr
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada.,E. Dermer and A. Spahr are co-first authors of this article
| | - L T Tran
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - A Mirchi
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - F Pelletier
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - K Guerrero
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - S Ahmed
- 27364North Bay Regional Health Centre, North Bay, Ontario, Canada
| | - B Brais
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada
| | - N Braverman
- Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - D Buhas
- Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada
| | - S Chandratre
- Department of Pediatric Neurology, 6397Oxford University Hospitals, Oxford, United Kingdom
| | - S Chenier
- Department of Medical Genetics, 7321University of Sherbrooke, Sherbrooke, Québec, Canada
| | - N Chrestian
- Division of Pediatric Neurology, 12369Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Québec, Canada.,Department of Pediatrics, 12369Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Québec, Canada
| | - M Desmeules
- Department of Pediatrics, Saguenay, Chicoutimi, Québec, Canada
| | - M E Dilenge
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada
| | - J Laflamme
- Department of Pediatrics, 12369Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Québec, Canada
| | - A Larbrisseau
- Department of Pediatrics, 5622University of Montreal, Montréal, Québec, Canada.,Department of Neurology, CHU Saint-Justine, Montréal, Québec, Canada
| | - G Legault
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada
| | - K Y Lim
- Department of Pediatric Neurology, Providence Pediatric Neurology-St. Vincent, Portland, OR, USA
| | - C Maftei
- Department of Pediatrics, Division of Medical Genetics, CHU Saint-Justine, Montreal University, Montréal, Québec, Canada
| | - P Major
- Department of Pediatrics, 5622University of Montreal, Montréal, Québec, Canada
| | - E Malvey-Dorn
- Department of Pediatrics, All About Children Pediatrics Eden Prairie, St. Louis Park, MN, USA
| | - P Marois
- Department of Pediatrics, 5622University of Montreal, Montréal, Québec, Canada
| | - J Mitchell
- Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - A Nadeau
- Department of Pediatric Neurology, University of Sherbrooke, Sherbrooke, Québec, Canada
| | - B Osterman
- Department of Pediatrics, 5622University of Montreal, Montréal, Québec, Canada.,Department of Neurology, CHU Saint-Justine, Montréal, Québec, Canada
| | - I Paradis
- CIUSSS de l'Est-de-l'Île-de-Montréal, CLSC de Rivière-des-Prairies, Montréal, Québec, Canada
| | - D Pohl
- Division of Neurology, 274065Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada
| | - J Reggin
- Department of Pediatric Neurology, Providence Child Neurology, Spokane, Washington, United States
| | - E Riou
- Department of Pediatric Neurology, University of Sherbrooke, Sherbrooke, Québec, Canada
| | - G Roedde
- Latchford Medical Centre, Latchford, Ontario, Canada
| | - E Rossignol
- Brain and Child Development, CHU Saint-Justine Research Center, Montréal, Québec, Canada
| | - G Sébire
- Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - M Shevell
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - M Srour
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| | - M Sylvain
- Division of Pediatric Neurology, 12369Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Québec, Canada.,Department of Pediatrics, 12369Centre Mère-Enfant Soleil du CHU de Québec-Université Laval, Québec, Canada
| | - M Tarnopolsky
- Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
| | - S Venkateswaran
- Department of Pediatrics, CHEO Research Institute, Ottawa, Ontario, Canada
| | - M Sullivan
- Department of Psychology, McGill University, Montréal, Québec, Canada
| | - G Bernard
- Department of Neurology and Neurosurgery, 54473McGill University, Montréal, Québec Canada.,Department of Pediatrics, 54473McGill University, Montréal, Québec Canada.,Department of Human Genetics, 54473McGill University, Montréal, Québec, Canada.,Department of Specialized Medicine, Division of Medical Genetics, 507266McGill University Health Centre, Montréal, Québec, Canada.,Child Health and Human Development Program, 507266Research Institute of the McGill University Health Center, Montréal, Québec, Canada
| |
Collapse
|
18
|
Colas M, Vanhaecke C, Courtieu C, Lambert D, Lihoreau T, Merle C, Schmidt-Guerre AR, Ginet-Mermet I, Viguier M, Pelletier F, Aubin F. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men: real-life experience from three sexual health clinics in France. J Eur Acad Dermatol Venereol 2020; 35:e94-e96. [PMID: 32697864 DOI: 10.1111/jdv.16832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M Colas
- Service de Dermatologie, CHU et UFR Santé, Université de Franche-Comté, Besançon, France
| | - C Vanhaecke
- Service de Dermatologie, CeGIDD, CHU, Reims, France
| | - C Courtieu
- CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France
| | - D Lambert
- Service de Dermatologie, CeGIDD, CHU, Reims, France
| | - T Lihoreau
- Inserm, CIC 1431, Centre d'Investigation Clinique, CHU, Besançon, France
| | - C Merle
- Service de Dermatologie, CHI de Haute-Saône, Vesoul, France
| | - A R Schmidt-Guerre
- CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France
| | - I Ginet-Mermet
- CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France
| | - M Viguier
- Service de Dermatologie, CeGIDD, CHU, Reims, France
| | - F Pelletier
- Service de Dermatologie, CHU et UFR Santé, Université de Franche-Comté, Besançon, France.,CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France.,INSERM UMR 1098, Université de Franche-Comté, Besançon, France
| | - F Aubin
- Service de Dermatologie, CHU et UFR Santé, Université de Franche-Comté, Besançon, France.,INSERM UMR 1098, Université de Franche-Comté, Besançon, France
| |
Collapse
|
19
|
Castelain F, Kerre S, Carlet C, Goossens A, Girardin P, Pelletier F, Aubin F. Allergic contact dermatitis from carbomers: two case report. Contact Dermatitis 2020; 83:326-328. [DOI: 10.1111/cod.13616] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2020] [Revised: 05/14/2020] [Accepted: 05/18/2020] [Indexed: 11/29/2022]
Affiliation(s)
- Florence Castelain
- Department of Dermatology, Allergology Unit University Hospital of Besançon Besançon France
| | - Stefan Kerre
- Dermatologist, Dermatology Clinic Aarschot Belgium
| | - Clémentine Carlet
- Department of Dermatology, Allergology Unit University Hospital of Besançon Besançon France
| | - An Goossens
- Department of Dermatology University Hospitals, KU Leuven Leuven Belgium
| | - Pascal Girardin
- Department of Dermatology, Allergology Unit University Hospital of Besançon Besançon France
| | - Fabien Pelletier
- Department of Dermatology, Allergology Unit University Hospital of Besançon Besançon France
- Dermatology Clinic University of Franche‐Comté, Inserm U1098 RIGHT Besançon France
| | - Francois Aubin
- Department of Dermatology, Allergology Unit University Hospital of Besançon Besançon France
- Dermatology Clinic University of Franche‐Comté, Inserm U1098 RIGHT Besançon France
| |
Collapse
|
20
|
Philippe F, Mahmoudi Y, Cinq-Mars D, Lefrançois M, Moula N, Palacios J, Pelletier F, Godbout S. Comparison of egg production, quality and composition in three production systems for laying hens. Livest Sci 2020. [DOI: 10.1016/j.livsci.2020.103917] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
21
|
Dresco F, Puzenat E, Delobeau M, Salard D, Lihoreau T, Pelletier F, Aubin F. [Resistant and progressive cutaneous lupus erythematosus treated with belimumab: A retrospective monocentric study]. Rev Med Interne 2020; 41:152-159. [PMID: 31980188 DOI: 10.1016/j.revmed.2019.12.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 11/25/2019] [Accepted: 12/08/2019] [Indexed: 12/20/2022]
Abstract
BACKGROUND Belimumab is currently approved for the treatment of active systemic lupus erythematosus (SLE). The aim of our study was to evaluate the efficacy of belimumab in the treatment of cutaneous lupus erythematosus (CLE), resistant to conventional therapy. PATIENTS AND METHODS Seven patients with resistant and progressive LEC and treated with belimumab were retrospectively analyzed. The efficacy and safety of belimumab were evaluated with the CLASI, RCLASI and DLQI scores, after 6 to 12 months of treatment. RESULTS Eighty-three percent of patients demonstrated a significant clinical improvement based on the CLASI and RCLASI activity scores, including 1 complete and 4 partial responses, without worsening of CLASI and RCLASI damage scores. Eighty percent of patients also showed an improvement of their quality of life (DLQI). Oral corticosteroids were discontinued in all patients. Tolerance was acceptable with only one serious adverse event (bacteriema). CONCLUSION Our study suggests the clinical efficiency of belimumab in a series of 7 patients presenting a resistant and progressive CLE.
Collapse
Affiliation(s)
- F Dresco
- Service de dermatologie, UMR Inserm 1098, CHU et université de Franche Comté, Besançon, France
| | - E Puzenat
- Service de dermatologie, UMR Inserm 1098, CHU et université de Franche Comté, Besançon, France
| | - M Delobeau
- Service de dermatologie, centre hospitalier de Haute Comté, Pontarlier, France
| | - D Salard
- Service de dermatologie, centre hospitalier de Haute Comté, Pontarlier, France
| | | | - F Pelletier
- Service de dermatologie, UMR Inserm 1098, CHU et université de Franche Comté, Besançon, France
| | - F Aubin
- Service de dermatologie, UMR Inserm 1098, CHU et université de Franche Comté, Besançon, France.
| |
Collapse
|
22
|
Dresco F, Delobeau M, Salard D, Lihoreau T, Pelletier F, Aubin F, Puzenat E. Lupus érythémateux cutanés réfractaires traités par bélimumab : étude descriptive monocentrique. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
23
|
Colas M, Maisonette Y, Pelletier F, Aubin F. Dyskératose acantholytique papuleuse ou focale. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
24
|
Jeand’heur A, Aubin F, Parratte B, Pelletier F. Traitement par patchs de capsaïcine des vestibulodynies provoquées. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
25
|
Sueur P, Castelain F, Girardin P, Moumane L, Jeand’heur A, Pelletier F. Dermite de contact aux protéines après injection de toxine botulinique en lien avec une allergie à l’albumine humaine. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
26
|
Jeand'heur A, Pelletier F, Girardin P, Moumane L, Aubin F, Castelain F. A case of immediate hypersensitivity reaction after an oral administration of patent blue dye. Contact Dermatitis 2019; 82:116-118. [PMID: 31566746 DOI: 10.1111/cod.13402] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2019] [Revised: 09/17/2019] [Accepted: 09/22/2019] [Indexed: 11/26/2022]
Affiliation(s)
- Anne Jeand'heur
- Department of Dermatology and EA3181, University Hospital and University of Franche Comté, Besançon, France
| | - Fabien Pelletier
- Department of Dermatology and EA3181, University Hospital and University of Franche Comté, Besançon, France
| | - Pascal Girardin
- Department of Dermatology and EA3181, University Hospital and University of Franche Comté, Besançon, France
| | | | - François Aubin
- Department of Dermatology and EA3181, University Hospital and University of Franche Comté, Besançon, France
| | - Florence Castelain
- Department of Dermatology and EA3181, University Hospital and University of Franche Comté, Besançon, France
| |
Collapse
|
27
|
Affiliation(s)
- Charlée Nardin
- Department of Dermatology, University of Bourgogne-Franche Comté, FR-25000 Besançon, France.
| | | | | | | |
Collapse
|
28
|
Castagna J, Aubin F, Pelletier F. [Anogenital granulomatosis as extradigestive Crohn disease: Efficiency of adalimumab therapy]. Rev Med Interne 2019; 40:677-679. [PMID: 31451228 DOI: 10.1016/j.revmed.2019.05.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Revised: 05/20/2019] [Accepted: 05/31/2019] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Anogenital granulomatosis is a rare disease which is actually considered as a metastatic lesion of Crohn disease (CD). OBSERVATION A 53-year-old woman presented with intermittent vulvar and anoperineal lesions since adolescence, seeping and painful during sexual intercourse. We observed an infiltrative and asymmetric oedema of labia majora, perianal oedematous vegetative pseudo-marisca, and groin fold and perianal linear "knife-like" ulcerations. Pathological analysis revealed noncaseating giant cell granulomas. The diagnosis of CD was made. Investigations did not show any intestinal involvement. Anti-TNFα therapy with adalimumab was dramatically efficient. CONCLUSION Anogenital granulomatosis often precedes intestinal lesions but may also be isolated as in our case. Although treatment is difficult, anti-TNFα seem promising tools.
Collapse
Affiliation(s)
- J Castagna
- Service de dermatologie et allergologie, CHU Besançon, 3, boulevard Fleming, 25000 Besançon, France.
| | - F Aubin
- Service de dermatologie et allergologie, CHU Besançon, 3, boulevard Fleming, 25000 Besançon, France
| | - F Pelletier
- Service de dermatologie et allergologie, CHU Besançon, 3, boulevard Fleming, 25000 Besançon, France
| |
Collapse
|
29
|
Abstract
Human harvest can induce selection on life history and morphological traits, leading to ecological and evolutionary responses. Our understanding of harvest-induced selection on behavioral traits is, however, very limited. Here, we assessed whether hunters harvest, consciously or not, individuals with specific behavioral traits. We used long-term, detailed behavioral and survival data of a heavily harvested brown bear (Ursus arctos) population in Sweden. We found that hunters harvested male bears that were less active during legal hunting hours and had lower movement rates. Also, hunters harvested male and female bears that used habitats closer to roads. We provide an empirical example that individual behavior can modulate vulnerability to hunting and that hunters could exert a selective pressure on wildlife behaviors. This study increases our understanding of the complex interactions between harvest method, human behavior, and animal behavior that are at play in harvest-induced selection and provides better insight into the full effects of human harvest on wild populations.
Collapse
Affiliation(s)
- M Leclerc
- Canada Research Chair in Evolutionary Demography and Conservation & Centre for Northern Studies, Département de biologie, Université de Sherbrooke, Sherbrooke, J1K2R1, Canada.
| | - A Zedrosser
- Faculty of Technology, Natural Sciences and Maritime Sciences, Department of Natural Sciences and Environmental Health, University of South-Eastern Norway, N-3800 Bø i, Telemark, Norway. .,Department of Integrative Biology, Institute of Wildlife Biology and Game Management, University of Natural Resources and Life Sciences, Vienna, Gregor Mendel Str. 33, A - 1180, Vienna, Austria.
| | - J E Swenson
- Faculty of Environmental Sciences and Natural Resource Management, Norwegian University of Life Sciences, PO Box 5003, NO - 1432 Ås, Oslo, Norway.,Norwegian Institute for Nature Research, NO-7485, Trondheim, Norway
| | - F Pelletier
- Canada Research Chair in Evolutionary Demography and Conservation & Centre for Northern Studies, Département de biologie, Université de Sherbrooke, Sherbrooke, J1K2R1, Canada
| |
Collapse
|
30
|
Castagna J, Jeand'heur A, Grillet F, Castelain F, Roux P, Aubin F, Manzoni P, Pelletier F. A challenging diagnosis of exercise-related transient abdominal pain. J Sports Med Phys Fitness 2019; 59:1934-1936. [PMID: 31311236 DOI: 10.23736/s0022-4707.19.09176-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
A 17-year-old woman, high-performance triathlete, presented transient abdominal pain, face angioedema and sometimes syncope during exercise. Exercise-induced anaphylaxis was suspected at first. Allergic explorations with skin prick tests were negative but wheat flour specific IgE and recombinant rTri a14 (LTP) were weakly positive. However, wheat eviction did not improve the symptoms and stress test after wheat oral challenge did not show any signs of anaphylaxis. An abdominal ultrasound revealed peak expiratory velocities with a stenosis evaluated at 70 to 80 percent with turbulences in the celiac artery, confirmed by computed tomography angiogram. The diagnosis of exercise-induced median arcuate ligament syndrome (MALS) was retained and we discuss here the challenging diagnosis mimicking exercise-induced anaphylaxis.
Collapse
Affiliation(s)
- Julie Castagna
- Department of Dermatology and Allergy, Besançon University Hospital, Besançon, France -
| | - Anne Jeand'heur
- Department of Dermatology and Allergy, Besançon University Hospital, Besançon, France
| | - Franck Grillet
- Department of Imaging, Besançon University Hospital, Besançon, France
| | - Florence Castelain
- Department of Dermatology and Allergy, Besançon University Hospital, Besançon, France
| | - Pauline Roux
- Department of Pneumology and Respiratory Explorations, Besançon University Hospital, Besançon, France
| | - François Aubin
- Department of Dermatology and Allergy, Besançon University Hospital, Besançon, France
| | - Philippe Manzoni
- Department of Imaging, Besançon University Hospital, Besançon, France
| | - Fabien Pelletier
- Department of Dermatology and Allergy, Besançon University Hospital, Besançon, France
| |
Collapse
|
31
|
Roche H, Bouiller K, Puzenat E, Deveza E, Roche B, Pelletier F, van de Laak A, Dupond AS, Nardin C, Aubin F. Efficacy and survival of biologic agents in psoriasis: a practical real-life 12-year experience in a French dermatology department. J DERMATOL TREAT 2019; 30:540-544. [PMID: 29848153 DOI: 10.1080/09546634.2018.1480746] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Background: Drug survival in a real-life setting is critical to long-term use of biologics for psoriasis. Objective: We describe our 12-year experience with biologics in psoriasis patients. Patients and Methods: All patients treated with biologics including infliximab, adalimumab (ADA), etanercept (ETA), and ustekinumab (UST) for psoriasis vulgaris between January 2005 and December 2016 were retrospectively analyzed. Results: In total, 545 treatment series were administered to 269 patients, including 211 treatment series with ADA, 135 with ETA, 77 with infliximab, and 122 with UST. ADA and ETA were initiated most often as first-line therapy; 65.3% of treatment sequences were discontinued. UST had the highest drug survival. The major reason for treatment termination was a loss of efficacy (44.9%). Definitive discontinuation increased with the number of biologic therapy sequences. Limitations: Subjects were not randomized to the different treatments. Conclusions: In a long-term real-life setting, drug survival of UST is better than that of TNF-a inhibitors for both biologic-naive and biologic-experienced patients with psoriasis.
Collapse
Affiliation(s)
- Hélène Roche
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| | - Kevin Bouiller
- b Department of Internal Medicine, University Hospital , Besançon , France
| | - Eve Puzenat
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| | - Elise Deveza
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| | - Blandine Roche
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| | - Fabien Pelletier
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| | - Alison van de Laak
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| | | | - Charlée Nardin
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| | - François Aubin
- a Department of Dermatology, University Hospital and EA3181, University of Franche Comté , Besançon , France
| |
Collapse
|
32
|
Carlet C, Castelain F, Pelletier F, Aubin F, Raison-Peyron N. Postoperative purpuric contact dermatitis: Think about antiseptics. Contact Dermatitis 2019; 81:215-216. [PMID: 30919977 DOI: 10.1111/cod.13277] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Accepted: 03/26/2019] [Indexed: 11/30/2022]
Affiliation(s)
- Clémentine Carlet
- Department of Dermatology, University Hospital Centre of Besançon, Besançon, France
| | - Florence Castelain
- Department of Dermatology, University Hospital Centre of Besançon, Besançon, France
| | - Fabien Pelletier
- Department of Dermatology, University Hospital Centre of Besançon, Besançon, France
| | - François Aubin
- Department of Dermatology, University Hospital Centre of Besançon, Besançon, France
| | - Nadia Raison-Peyron
- Department of Dermatology, Saint Eloi Hospital, University Hospital Centre of Montpellier, Montpellier, France
| |
Collapse
|
33
|
Affiliation(s)
- C Nardin
- Dermatologie, Centre Hospitalier de Belfort Montbéliard, Montbéliard
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| | - A S Dupond
- Dermatologie, Centre Hospitalier de Belfort Montbéliard, Montbéliard
| | - F Pelletier
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| | - E Puzenat
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| | - F Aubin
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| |
Collapse
|
34
|
Affiliation(s)
- C Nardin
- Dermatologie, Centre Hospitalier de Belfort Montbéliard, Montbéliard
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| | - A S Dupond
- Dermatologie, Centre Hospitalier de Belfort Montbéliard, Montbéliard
| | - F Pelletier
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| | - E Puzenat
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| | - F Aubin
- Dermatologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| |
Collapse
|
35
|
Bouillet L, Defendi F, Hardy G, Cesbron JY, Boccon-Gibod I, Deroux A, Mansard C, Launay D, Gompel A, Floccard B, Jaussaud R, Beaudouin E, Armengol G, Olliver Y, Gayet S, Du Than A, Sailler L, Guez S, Sarrat A, Sorin L, de Moreuil C, Pelletier F, Javaud N, Marmion N, Fain O, Fauré J, Dumestre-Pérard C. Diagnostic biologique des angioedèmes bradykiniques : les recommandations du CREAK. Presse Med 2019; 48:55-62. [DOI: 10.1016/j.lpm.2018.06.015] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2018] [Revised: 06/01/2018] [Accepted: 06/25/2018] [Indexed: 02/08/2023] Open
|
36
|
Roche H, Bouiller K, Castelain F, Vigan M, Aubin F, Pelletier F. Évaluation en vie réelle de l’efficacité, de la qualité de vie et de l’adaptation posologique de l’omalizumab dans l’urticaire chronique. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
37
|
Larsabal M, Ly S, Sbidian E, Moyal‐Barracco M, Dauendorffer J, Dupin N, Richard M, Chosidow O, Beylot‐Barry M, Abdo I, Acquitter M, Breteque Mignot MA, Amici J, Archier E, Aubin F, Barthelemy H, Baubion E, Beneton N, Bolac C, Bouilly D, Bourseau‐Quetier C, Brenaut E, Buzenet C, Camus M, Celerier P, Chabbert C, Chamaillard M, Charles S, Darrigade A, Delarue M, Depaire F, Devaux S, Do‐Pham G, Duval‐Modeste A, Fabre F, Fauconneau A, Fite C, Fleuret C, Girard C, Grande S, Guillet S, Hacard F, Hegazy S, Hosteing S, Jacquin M, Jegou M, Joly P, Jouary T, Julien D, Kemula M, Kostrzewa E, Lacour J, Legrain V, Livideanu C, Lu D, Maccari F, Magne F, Martin C, Meunier L, Misery L, Parier J, Pelletier F, Perrussel M, Petit‐Fauconneau A, Peyrot I, Plantin P, Pruvost‐Balland C, Regnier E, Reynier‐Rezzi J, Salzes C, Seneschal J, Shollhammer M, Souteyrand A, Staumont D, Toulemonde A, Vanhaecke C, Vedie A, Versapuech J, Vigan M, Viguier M, Villani A. GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis. Br J Dermatol 2018; 180:647-656. [DOI: 10.1111/bjd.17147] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/31/2018] [Indexed: 12/01/2022]
Affiliation(s)
- M. Larsabal
- Department of Dermatology Bordeaux University Hospital Bordeaux University Bordeaux France
| | - S. Ly
- Department of Dermatology Bordeaux University Hospital Bordeaux University Bordeaux France
- Vulvology Study Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | - E. Sbidian
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Henri‐Mondor Hospital, Public Assistance – Paris Hospitals (AP‐HP) CréteilFrance
- Virus,Immunity and Cancer University‐Hospital Complex (DHU VIC) EA 7379 Epidemiology in Dermatology and Evaluation of Treatments (EpiDermE) Paris‐Est University Créteil (UPEC) CréteilFrance
| | - M. Moyal‐Barracco
- Vulvology Study Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Cochin Tarnier Hospital Paris Descartes University ParisFrance
| | - J.‐N. Dauendorffer
- Vulvology Study Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Saint‐Louis Hospital Paris France
| | - N. Dupin
- Department of Dermatology Cochin Tarnier Hospital Paris Descartes University ParisFrance
- Dermatological Infectiology and Sexually Transmitted Diseases Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | - M.A. Richard
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Timone Hospital, Public Assistance–Marseille Hospitals Aix‐Marseille University UMR 911, INSERM CRO2, “Centre de recherche en oncologie biologique et oncopharmacologie” Marseille France
| | - O. Chosidow
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Henri‐Mondor Hospital, Public Assistance – Paris Hospitals (AP‐HP) CréteilFrance
- Virus,Immunity and Cancer University‐Hospital Complex (DHU VIC) EA 7379 Epidemiology in Dermatology and Evaluation of Treatments (EpiDermE) Paris‐Est University Créteil (UPEC) CréteilFrance
- Dermatological Infectiology and Sexually Transmitted Diseases Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | - M. Beylot‐Barry
- Department of Dermatology Bordeaux University Hospital Bordeaux University Bordeaux France
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Bellavance V, Bélisle M, Savage J, Pelletier F, Garant D. Influence of agricultural intensification on prey availability and nestling diet in Tree Swallows (Tachycineta bicolor). CAN J ZOOL 2018. [DOI: 10.1139/cjz-2017-0229] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Over the last decades, aerial insectivorous birds have been declining in both North America and Europe. Those declines have been hypothetically attributed to a decrease in prey availability caused by agricultural intensification, but empirical evidence remains scarce. Here, we quantify the effect of landscape composition on the abundance and diversity of potential prey of Tree Swallows (Tachycineta bicolor (Vieillot, 1808)) and on nestling diet in southern Quebec, Canada. We collected food boluses from nestlings and compared their composition with spatiotemporally corresponding samples from traps on farms distributed along a gradient of agricultural intensification. The diet of nestlings was mostly composed of Diptera, both in biomass and abundance, but by mid-June, these decreased with increasing proportions of intensively cultivated crops within 500 m of the nests. Trap catches for Diptera and all arthropods combined followed the same trends. Yet, the associations between Diptera subgroups (Nematocera, non-schizophoran Brachycera, Schizophora (Calyptratae), and Schizophora (Acalyptratae)) and landscape composition differed between traps and boluses, suggesting that prey selection was altered by agricultural intensification. Our results suggest that agriculture can alter the availability of preferred prey for aerial insectivores, and further studies should evaluate the impact of prey availability to explain the decline of aerial insectivores.
Collapse
Affiliation(s)
- V. Bellavance
- Département de biologie, Université de Sherbrooke, 2500 boulevard de l’Université, Sherbrooke, QC J1K 2R1, Canada
- Biology Department, Bishop’s University, 2600 College Street, Sherbrooke, QC J1M 1Z7, Canada
| | - M. Bélisle
- Département de biologie, Université de Sherbrooke, 2500 boulevard de l’Université, Sherbrooke, QC J1K 2R1, Canada
| | - J. Savage
- Biology Department, Bishop’s University, 2600 College Street, Sherbrooke, QC J1M 1Z7, Canada
| | - F. Pelletier
- Département de biologie, Université de Sherbrooke, 2500 boulevard de l’Université, Sherbrooke, QC J1K 2R1, Canada
| | - D. Garant
- Département de biologie, Université de Sherbrooke, 2500 boulevard de l’Université, Sherbrooke, QC J1K 2R1, Canada
| |
Collapse
|
39
|
Castelain F, Girardin P, Penven E, Pelletier F. Occupational contact dermatitis caused by polyurethane foam: 6 cases. Contact Dermatitis 2018; 79:52-54. [PMID: 29635841 DOI: 10.1111/cod.12989] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2018] [Accepted: 02/08/2018] [Indexed: 11/29/2022]
Affiliation(s)
- Florence Castelain
- Department of Dermatology, University Hospital of Besançon, Besancon, France
| | - Pascal Girardin
- Department of Dermatology, University Hospital of Besançon, Besancon, France
| | - Emmanuelle Penven
- Occupational Diseases Department, University Hospital of Nancy, Nancy, France
| | - Fabien Pelletier
- Department of Dermatology, University Hospital of Besançon, Besancon, France
| |
Collapse
|
40
|
Aubin F, Courtois J, Puzenat E, Nardin C, Castelain F, Pelletier F, Gastaldi-Ménager C. Phototherapy in France: quantitative data (2007-2016) from the National Health Insurance Register. J Eur Acad Dermatol Venereol 2017; 32:e224-e225. [DOI: 10.1111/jdv.14746] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- F. Aubin
- Department of Dermatology; University of Bourgogne Franche Comté, EA3181 and University Hospital; Besançon France
| | - J. Courtois
- Caisse Nationale d'Assurance Maladie; Paris France
| | - E. Puzenat
- Department of Dermatology; University of Bourgogne Franche Comté, EA3181 and University Hospital; Besançon France
| | - C. Nardin
- Department of Dermatology; University of Bourgogne Franche Comté, EA3181 and University Hospital; Besançon France
| | - F. Castelain
- Department of Dermatology; University of Bourgogne Franche Comté, EA3181 and University Hospital; Besançon France
| | - F. Pelletier
- Department of Dermatology; University of Bourgogne Franche Comté, EA3181 and University Hospital; Besançon France
| | | | | |
Collapse
|
41
|
Steyaert SMJG, Leclerc M, Pelletier F, Kindberg J, Brunberg S, Swenson JE, Zedrosser A. Human shields mediate sexual conflict in a top predator. Proc Biol Sci 2017; 283:rspb.2016.0906. [PMID: 27335423 PMCID: PMC4936045 DOI: 10.1098/rspb.2016.0906] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2016] [Accepted: 05/25/2016] [Indexed: 11/12/2022] Open
Abstract
Selecting the right habitat in a risky landscape is crucial for an individual's survival and reproduction. In predator-prey systems, prey often can anticipate the habitat use of their main predator and may use protective associates (i.e. typically an apex predator) as shields against predation. Although never tested, such mechanisms should also evolve in systems in which sexual conflict affects offspring survival. Here, we assessed the relationship between offspring survival and habitat selection, as well as the use of protective associates, in a system in which sexually selected infanticide (SSI), rather than interspecific predation, affects offspring survival. We used the Scandinavian brown bear (Ursus arctos) population with SSI in a human-dominated landscape as our model system. Bears, especially adult males, generally avoid humans in our study system. We used resource selection functions to contrast habitat selection of GPS-collared mothers that were successful (i.e. surviving litters, n = 19) and unsuccessful (i.e. complete litter loss, n = 11) in keeping their young during the mating season (2005-2012). Habitat selection was indeed a predictor of litter survival. Successful mothers were more likely to use humans as protective associates, whereas unsuccessful mothers avoided humans. Our results suggest that principles of predator-prey and fear ecology theory (e.g. non-consumptive and cascading effects) can also be applied to the context of sexual conflict.
Collapse
Affiliation(s)
- S M J G Steyaert
- Department of Ecology and Natural Resource Management, Norwegian University of Life Sciences, 1432 Ås, Norway Faculty of Arts and Sciences, Department of Environmental and Health Studies, University College of Southeast Norway, 3800 Bø, Norway
| | - M Leclerc
- Département de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada J1K 2R1
| | - F Pelletier
- Département de biologie, Université de Sherbrooke, Sherbrooke, Québec, Canada J1K 2R1
| | - J Kindberg
- Department of Wildlife, Fish and Environmental Studies, Swedish University of Agricultural Sciences, 90183 Umeå, Sweden Norwegian Institute for Nature Research, 7485 Trondheim, Norway
| | - S Brunberg
- Department of Ecology and Natural Resource Management, Norwegian University of Life Sciences, 1432 Ås, Norway
| | - J E Swenson
- Department of Ecology and Natural Resource Management, Norwegian University of Life Sciences, 1432 Ås, Norway Norwegian Institute for Nature Research, 7485 Trondheim, Norway
| | - A Zedrosser
- Faculty of Arts and Sciences, Department of Environmental and Health Studies, University College of Southeast Norway, 3800 Bø, Norway Institute of Wildlife Biology and Game Management, University of Natural Resources and Life Sciences, 1180 Vienna, Austria
| |
Collapse
|
42
|
Nardin C, Colas M, Curie V, Pelletier F, Puzenat E, Aubin F. Grossesse compliquée d’un avortement spontané précoce après stérilisation tubaire chez une patiente traitée par sécukinumab pour un psoriasis. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
43
|
Dresco F, Salard D, Delobeau M, Pelletier F, Aubin F, Puzenat E. Lupus érythémateux cutané réfractaire traité par bélimumab : à propos de 4 cas. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
44
|
Schmaier AH, Cicardi M, Reshef A, Moldovan D, Mócsai A, López-Trascasa M, Lera AL, Brown NJ, Germenis AE, Filippelli-Silva R, Duarte DA, Martin RP, Veronez CL, Bouvier M, Bader M, Costa-Neto CM, Pesquero JB, Charest-Morin X, Marceau F, Rivard GÉ, Bonnefoy A, Wagner É, Debreczeni ML, Németh Z, Kajdácsi E, Schwaner E, Cervenak L, Oroszlán G, Szilágyi A, Dani R, Závodszky P, Gál P, Dobó J, Hébert J, Vincent M, Boursiquot JN, Chapdeleine H, Desjardins M, Laramée B, Gagnon R, Payette N, Lepeshkina O, Charignon D, Ghannam A, Ponard D, Drouet C, Joseph K, Tholanikunnel BG, Sexton DJ, Kaplan AP, Loffredo S, Bova M, Ferrara AL, Petraroli A, Suffritti C, Veszeli N, Zanichelli A, Farkas H, Marone G, Luyasu S, Favier B, Martin L, Kőhalmi KV, Temesszentandrási G, Várnai K, Varga L, Zuraw BL, Feussner A, Tortorici MA, Pawaskar D, Li HH, Anderson J, Bernstein JA, Zhang Y, Pragst I, Aygören-Pürsün E, Jacobson K, Christensen J, Van Leerberghe A, Wang Y, Schranz J, Martinez-Saguer I, Soteres D, Steiner U, Panovska VG, Rae W, Aberer W, Huissoon A, Bygum A, Magerl M, Graff J, Longhurst H, Lleonart R, Fang L, Cornpropst M, Clemons D, Mathis A, Collis P, Dobo S, Sheridan WP, Maurer M, Riedl MA, Craig T, Banerji A, Shennak M, Yang W, Baptista J, Busse P, Kalfus I, McDonald A, Qian S, Roberts A, Panousis C, Green T, Gille A, Zamanakou M, Loules G, Csuka D, Psarros F, Parsopoulou F, Speletas M, Firinu D, De Pasquale TMA, Zoli A, Radice A, Pizzimenti S, Manoussakis E, Konstantinou GN, Bafunno V, Montinaro V, Cancian M, Margaglione M, Bork K, Wulff K, Witzke G, Hardt J, Bouillet L, Caballero T, Grumach AS, Pommie C, Andresen I, Ettingshausen CE, Gutowski Z, Andritschke K, Linde R, Andrási N, Szilágyi T, Leibovich-Nassi I, Symons C, Dempster J, Boccon-Gibod I, Pagnier A, Lehmann A, Kreiberg KB, Nieto SA, Martins R, Martins R, Menendez A, Valle SOR, Olivares M, Hernandez-Landeros ME, Nievas E, Fili N, Barrera OM, Bailleau R, Gallardo-Olivos AM, Grau M, Rodriguez-Galindo J, Carabantes MJO, Zapata-Venegas E, Alfonso MM, Rosario-Grauert M, Ratti M, Vaszquez D, Josviack D, Landivar-Salinas LF, Calderón-Llosa OME, Campilay-Sarmiento R, Raby P, Fabiani J, Lumry WR, Feuersenger H, Watson DJ, Machnig T, Lamacchia D, Hernanz A, Alvez A, Lluncor M, Pedrosa M, Cabañas R, Prior N, Nordenfelt P, Nilsson M, Lindfors A, Wahlgren CF, Björkander J, Hakl R, Kuklínek P, Krčmová I, Hanzlíková J, Vachová M, Zachová R, Sobotková M, Strenková J, Litzman J, Palasopoulou M, Tsinti G, Gianni P, Kompoti M, Garrido S, Dyga W, Bogdali A, Obtułowicz A, Tomasz M, Czarnobilska E, Obtulowicz K, Książek T, Koncz A, Gulyás D, Staevska M, Jesenak M, Hrubiskova K, Bellizzi L, Relan A, Wu MA, Castelli A, Colombo R, Podda G, Del Medico M, Catena E, Casella F, Perego F, Afifi NA, Tobaldini E, Montano N, Sánchez-Jareño M, Stobiecki M, Obtułowicz K, Guryanova I, Polyakova E, Lebedz V, Salivonchik A, Aleshkevich S, Belevtsev M, Nordmann-Kleiner M, Trainotti S, Hahn J, Greve J, Zabrodska L, Alonso MLO, Tórtora RP, França AT, Ribeiro MG, Fu L, Kanani A, Lacuesta G, Waserman S, Betschel S, Espinosa MI, Contreras FA, Hrubisko M, Vavrova L, Banovcin P, Ayazi M, Fazlollahi MR, Saghafi S, Mohammadian S, Deshiry SN, Bidad K, Shoormasti RS, Mohammadzadeh I, Bemanian MH, Mahdaviani SA, Pourpak Z, Valerieva A, Vasileva M, Velikova T, Petkova E, Dimitrov V, Di Maulo R, Somech R, Golander H, Sifuentes EJ, Mansard C, Gompel A, Floccard B, Blanchard-Delaunay C, Launay D, Fain O, Sobel A, Gayet S, Amarger S, Armengol G, Ollivier Y, Zélinsky-Gurung A, Jeandel PY, Kanny G, Coppéré B, Dubrel M, Pelletier F, Du Thanh A, Trouiller S, Laurent J, De Moreuil C, Pajot CA, Belot A, Rodríguez A, Roa D, Prieto A, Baeza ML, Krusheva B, Almeida SKA, Constantino-Silva RN, Melo N, Simoes JA, Palma SMU, da Silva J, de Azevedo BF, Mansour E, González-Quevedo T, Marcos C, Lobera T, de San Pedro BS, Avilla E, Badiou J, Binkley K, Borici-Mazi R, Howlett L, Keith PK, Rowe A, Waite P, Billebeau A, Boccon-Gibbod I, Lis K, Laitman Y, Friedman E, Gokmen NM, Gulbahar O, Onay H, Koc ZP, Sin AZ. Abstracts from the 10th C1-inhibitor deficiency workshop. Allergy Asthma Clin Immunol 2017. [PMCID: PMC5496025 DOI: 10.1186/s13223-017-0198-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
45
|
Moreau J, Pelletier F, Biichle S, Mourey G, Puyraveau M, Badet N, Caubet M, Laresche C, Garnache-Ottou F, Saas P, Seilles E, Aubin F. Increased levels of circulating platelet-derived microparticles are associated with metastatic cutaneous melanoma. Exp Dermatol 2017; 26:961-963. [PMID: 28266752 DOI: 10.1111/exd.13339] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/14/2017] [Indexed: 11/30/2022]
Abstract
We investigated the plasma levels of PMPs in patients with 45 stage III and 45 stage IV melanoma. PMPs were characterised by flow cytometry and their thrombogenic activity. We also investigated the link between PMPs circulating levels and tumor burden. The circulating levels of PMPs were significantly higher in stage IV (8500 μL-1 ) than in patients with stage III (2041 μL-1 ) melanoma (P=.0001). We calculated a highly specific (93.3%) and predictive (91.7%) cut-off value (5311 μL-1 ) allowing the distinction between high-risk stage III and metastatic stage IV melanoma. The thrombogenic activity of PMPs was significantly higher in patients with stage IV melanoma (clotting time: 40.7 second vs 65 second, P=.0001). There was no significant association between the radiological tumoral syndrome and the plasma level of PMPs. Our data suggest the role of PMPs in metastatic progression of melanoma.
Collapse
Affiliation(s)
- Joséphine Moreau
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,Department of Dermatology, University Hospital, Besançon, France
| | - Fabien Pelletier
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,Department of Dermatology, University Hospital, Besançon, France
| | - Sabeha Biichle
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,Etablissement Français du Sang Bourgogne Franche Comte, Besançon, France
| | - Guillaume Mourey
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,Etablissement Français du Sang Bourgogne Franche Comte, Besançon, France
| | - Marc Puyraveau
- Clinical Methodology Center, Besançon University Hospital, Besançon, France
| | - Nicolas Badet
- Department of Radiology, Besançon University Hospital, Besançon, France
| | - Matthieu Caubet
- Department of Radiotherapy, Besançon University Hospital, Besançon, France
| | - Claire Laresche
- Department of Dermatology, University Hospital, Besançon, France
| | - Francine Garnache-Ottou
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,Etablissement Français du Sang Bourgogne Franche Comte, Besançon, France
| | - Philippe Saas
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,Etablissement Français du Sang Bourgogne Franche Comte, Besançon, France
| | - Estelle Seilles
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,Etablissement Français du Sang Bourgogne Franche Comte, Besançon, France
| | - François Aubin
- INSERM UMR 1098, University of Bourgogne Franche Comté, Besançon, France.,EA3181, University of Bourgogne Franche Comté, Besançon, France
| |
Collapse
|
46
|
Bourret A, Bélisle M, Pelletier F, Garant D. Evolutionary potential of morphological traits across different life-history stages. J Evol Biol 2017; 30:616-626. [PMID: 28000316 DOI: 10.1111/jeb.13031] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2016] [Accepted: 12/15/2016] [Indexed: 02/05/2023]
Affiliation(s)
- A. Bourret
- Département de Biologie; Université de Sherbrooke; Sherbrooke QC Canada
| | - M. Bélisle
- Département de Biologie; Université de Sherbrooke; Sherbrooke QC Canada
| | - F. Pelletier
- Département de Biologie; Université de Sherbrooke; Sherbrooke QC Canada
| | - D. Garant
- Département de Biologie; Université de Sherbrooke; Sherbrooke QC Canada
| |
Collapse
|
47
|
Janeiro MJ, Coltman DW, Festa-Bianchet M, Pelletier F, Morrissey MB. Towards robust evolutionary inference with integral projection models. J Evol Biol 2016; 30:270-288. [DOI: 10.1111/jeb.13000] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2016] [Revised: 08/29/2016] [Accepted: 09/23/2016] [Indexed: 02/05/2023]
Affiliation(s)
- M. J. Janeiro
- School of Biology; University of St Andrews; St Andrews Fife UK
- CESAM; Department of Biology; University of Aveiro; Aveiro Portugal
| | - D. W. Coltman
- Département de Biologie; Faculté des Sciences; Universitéde Sherbrooke; Québec QC Canada
| | - M. Festa-Bianchet
- Department of Biological Sciences; University of Alberta; Edmonton AB Canada
| | - F. Pelletier
- Department of Biological Sciences; University of Alberta; Edmonton AB Canada
| | - M. B. Morrissey
- School of Biology; University of St Andrews; St Andrews Fife UK
| |
Collapse
|
48
|
Castagna J, Castelain F, Girardin P, Pelletier F. Allergie aux sels d’aluminium et revaccination. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
49
|
Jacquin-Porretaz C, Pelletier F, Castelain F. Angiœdème bradykinique par déficit en C1 inhibiteur acquis : 4 cas. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
50
|
Hamel S, Gaillard JM, Yoccoz NG, Albon S, Côté SD, Craine JM, Festa-Bianchet M, Garel M, Lee P, Moss C, Nussey DH, Pelletier F, Stien A, Tveraa T. Cohort variation in individual body mass dissipates with age in large herbivores. ECOL MONOGR 2016. [DOI: 10.1002/ecm.1232] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- S. Hamel
- Department of Arctic and Marine Biology; Faculty of Biosciences, Fisheries and Economics; UiT The Arctic University of Norway; 9037 Tromsø Norway
| | - J.-M. Gaillard
- CNRS, UMR 5558 “Biométrie et Biologie Evolutive”; Université de Lyon, Université Lyon 1; F-69622 Villeurbanne France
| | - N. G. Yoccoz
- Department of Arctic and Marine Biology; Faculty of Biosciences, Fisheries and Economics; UiT The Arctic University of Norway; 9037 Tromsø Norway
| | - S. Albon
- The James Hutton Institute; Craigiebuckler Aberdeen AB15 8QH United Kingdom
| | - S. D. Côté
- Département de biologie and Centre d’études nordiques; Université Laval; Québec Québec G1V 0A6 Canada
| | | | - M. Festa-Bianchet
- Département de biologie and Centre d’études nordiques; Université de Sherbrooke; Sherbrooke Québec J1K 2R1 Canada
| | - M. Garel
- Office National de la Chasse et de la Faune Sauvage; Unité Faune de Montagne; 5 allée de Bethléem, Z.I. Mayencin 38610 Gières France
| | - P. Lee
- Behaviour and Evolution Research Group; School of Natural Sciences; University of Stirling; Stirling FK9 4LA United Kingdom
- Amboseli Trust for Elephants; P.O. Box 15135, Langata Nairobi 00509 Kenya
| | - C. Moss
- Amboseli Trust for Elephants; P.O. Box 15135, Langata Nairobi 00509 Kenya
| | - D. H. Nussey
- Institute of Evolutionary Biology; University of Edinburgh; The Kings Buildings, Ashworth Labs Charlotte Auerbach Road Edinburgh EH 3FL United Kingdom
| | - F. Pelletier
- Département de biologie and Centre d’études nordiques; Université de Sherbrooke; Sherbrooke Québec J1K 2R1 Canada
| | - A. Stien
- Norwegian Institute of Nature Research; Fram Centre NO-9296 Tromsø Norway
| | - T. Tveraa
- Norwegian Institute of Nature Research; Fram Centre NO-9296 Tromsø Norway
| |
Collapse
|